Achelios Therapeutics

Achelios' drug platform will address the needs of the pain patients. without concerns of GI safety, side effects, patient compliance, rapid onset of action

  • Stage Product In Development
  • Industry Biotechnology
  • Location Durham, NC, USA
  • Currency USD
  • Founded February 2012
  • Employees 9
  • Incorporation Type C-corp
  • Website achelios.com

Company Summary

ACHELIOS focuses on the development of topical drugs using its proprietary drug delivery platform to treat peripheral pain. Treatment of Temporomandibular pain (TMD) or LockJaw is our Lead indication. Our lead product is ideally suited for the treatment of this chronic condition with a high unmet medical need and no approved therapies Topofen™ demonstrated high efficacy and ability to reduce opioid use

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free